<DOC>
	<DOCNO>NCT02875587</DOCNO>
	<brief_summary>The aim study compare efficacy calcium gluconate infusion versus cabergoline prevention ovarian hyperstimulation syndrome ( OHSS ) patient pretreated GnRH agonist long protocol high risk OHSS .</brief_summary>
	<brief_title>Cabergoline Versus Calcium Gluconate Infusion Prevention Ovarian Hyperstimulation Syndrome</brief_title>
	<detailed_description>Ovarian hyperstimulation syndrome ( OHSS ) serious complication assist reproduction . Previous study reveal calcium gluconate infusion reduce risk OHSS . Other study reveal cabergoline ( potent dopamine receptor agonist D2 receptor ) effective prevent OHSS . The aim study compare efficacy calcium gluconate infusion versus cabergoline prevention ovarian hyperstimulation syndrome ( OHSS ) patient pretreated GnRH agonist long protocol high risk OHSS .</detailed_description>
	<mesh_term>Ovarian Hyperstimulation Syndrome</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<mesh_term>Cabergoline</mesh_term>
	<criteria>Patients stimulate use long luteal GnRH agonist protocol high risk develop OHSS [ 18 follicle ( &gt; 11mm ) serum estradiol â‰¥ 3000 pg/ml day HCG administration ] . Fibrosis lung Swelling inflammation around heart lung Hypertension Liver disease Heart valve disease allergy cabergoline ergot derivative .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>37 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>OHSS</keyword>
	<keyword>Infertility</keyword>
	<keyword>Cabergoline</keyword>
	<keyword>Calcium gluconate</keyword>
	<keyword>IVF-ET</keyword>
</DOC>